Barclays’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-38
| Closed | – | – | 5374 |
|
|
2020
Q4 | $0 | Hold |
38
| – | – | ﹤0.01% | 5260 |
|
|
2020
Q3 | $0 | Hold |
38
| – | – | ﹤0.01% | 5790 |
|
|
2020
Q2 | $0 | Hold |
38
| – | – | ﹤0.01% | 6500 |
|
|
2020
Q1 | $0 | Sell |
38
-40
| -51% | -$55 | ﹤0.01% | 6654 |
|
|
2019
Q4 | $0 | Sell |
78
-43
| -36% | -$65 | ﹤0.01% | 7072 |
|
|
2019
Q3 | $0 | Sell |
121
-34,998
| -100% | -$56.6K | ﹤0.01% | 7345 |
|
|
2019
Q2 | $45K | Buy |
35,119
+21,632
| +160% | +$39.8K | ﹤0.01% | 6151 |
|
|
2019
Q1 | $35K | Buy |
13,487
+13,406
| +16,551% | +$31.4K | ﹤0.01% | 6110 |
|
|
2018
Q4 | $0 | Sell |
81
-11,634
| -99% | -$32.6K | ﹤0.01% | 7571 |
|
|
2018
Q3 | $57K | Buy |
11,715
+9,605
| +455% | +$54.5K | ﹤0.01% | 6007 |
|
|
2018
Q2 | $13K | Sell |
2,110
-9,893
| -82% | -$73.8K | ﹤0.01% | 6432 |
|
|
2018
Q1 | $100K | Buy |
12,003
+6,277
| +110% | +$59.9K | ﹤0.01% | 5386 |
|
|
2017
Q4 | $59K | Sell |
5,726
-6,855
| -54% | -$65.8K | ﹤0.01% | 5654 |
|
|
2017
Q3 | $115K | Buy |
12,581
+6,590
| +110% | +$50.1K | ﹤0.01% | 4835 |
|
|
2017
Q2 | $44K | Sell |
5,991
-9,237
| -61% | -$69.7K | ﹤0.01% | 5430 |
|
|
2017
Q1 | $110K | Buy |
15,228
+11,266
| +284% | +$69.9K | ﹤0.01% | 4816 |
|
|
2016
Q4 | $22K | Buy |
3,962
+3,876
| +4,507% | +$26.2K | ﹤0.01% | 5588 |
|
|
2016
Q3 | $1K | Sell |
86
-100
| -54% | -$792 | ﹤0.01% | 6500 |
|
|
2016
Q2 | $2K | Buy |
186
+100
| +116% | +$954 | ﹤0.01% | 6012 |
|
|
2016
Q1 | $1K | Sell |
86
-179
| -68% | -$1.89K | ﹤0.01% | 6048 |
|
|
2015
Q4 | $3K | Buy |
+265
| New | +$4K | ﹤0.01% | 5711 |
|
Barclays's NEOS Position: Q1 2021 in Review
Barclays sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 38 shares.
Barclays first reported a position in NEOS in Q4 2015 and held it in 21 quarters. The position peaked at $115K in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Barclays reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Barclays sold 38 Neos Therapeutics, Inc shares in Q1 2021.
- Barclays first reported a position in Neos Therapeutics, Inc in Q4 2015 and held it in 21 quarters.
- Barclays's Neos Therapeutics, Inc position peaked at $115K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.